BAK - Conference and earnings call announcements

Braskem has collected hundreds of units of blood to support the health and well-being of the residents of Neal, West Virginia, and surrounding communities. Braskem ((BM&, FBOVESPA: BRKM3, BRKM5, and BRKM6, NYSE:BAK, LATIBEX: XBRK)), the largest polyolefins producer in the Americas as well as a market leader and pioneer producer of biopolymers on an industrial scale, recently hosted its 25th blood drive on Thursday, February 22nd at its production facility in Neal, West Virginia in partnership with the American Red Cross. This milestone reflects Braskem's commitment to making a positive impact and prioritizing the health and well-being of neighboring communities. Since 2014, Braskem and

Braskem's I'm greenTM bio-based polyethylene is made from sugarcane ethanol, a renewable resource that removes CO2 from the environment Braskem ((BM&, FBOVESPA: BRKM3, BRKM5 and BRKM6, NYSE:BAK, LATIBEX: XBRK)) today announced that it has been selected to participate in an upcoming segment in the "World's Greatest…!" television series that airs on Bloomberg Television. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230911548175/en/Green Ethylene Triunfo Petrochemical Complex (Photo: Business Wire) Currently in its 17th season, "World's Greatest…!" is a 30-minute show that is dedicated to highlighting the world's greatest compa

In May, Braskem distributed R$1.35 billion in additional dividends for fiscal year 2021 SÃO PAULO, May 12, 2022 /PRNewswire/ -- BRASKEM S.A. ((B3: BRKM3, BRKM5 and BRKM6, NYSE:BAK, LATIBEX: XBRK)) announces today its results for 1Q22. 1Q22 HIGHLIGHTS CONSOLIDATED In 1Q22, the Company's Recurring EBITDA was US$920 million, 19% lower than 4Q21, mainly due to: (i) the normalization of international spreads for main chemicals and resins in Brazil, for PP in the USA & Europe and for PE in Mexico; (ii) lower sales volume of main chemicals and resins in the Brazil segment; and (iii) the appreciation of the Brazilian real against the U.S. dollar of 6.3%. Compared to 1Q21, the Company's Recurring EBI